KDventures ABKDEVF 27 Equity-to-Asset is 0.99 as of Mar. 2026, which is 11% above its 10-year median of 0.89. GuruFocus rates KDEVF with a GF Score™ of 27/100 and a GF Value™ of $0.65. The stock has 3 warning signs investors should review. Among 1,415 Biotechnology companies, KDventures AB ranks better than 99.36% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. KDventures AB's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $118.58 Mil. KDventures AB's Total Assets for the quarter that ended in Mar. 2026 was $119.28 Mil.
Therefore, KDventures AB's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.99.
The historical rank and industry rank for KDventures AB's Equity-to-Asset or its related term are showing as below:
KDEVF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.07 Med: 0.89 Max: 0.99
Current: 0.99
During the past 13 years, the highest Equity to Asset Ratio of KDventures AB was 0.99. The lowest was 0.07. And the median was 0.89.
KDEVF's Equity-to-Asset is ranked better than 99.36% of 1415
companies
in the Biotechnology industry
Industry Median: 0.68
vs KDEVF: 0.99
KDventures AB (OTCPK:KDEVF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
KDventures AB Equity-to-Asset Related Terms
KDventures AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for KDventures AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDEVF vs VRTX, REGN, ALNY: Equity-to-Asset Comparison
For the Biotechnology subindustry, KDventures AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB Equity-to-Asset vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where KDventures AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
KDventures AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (KDEVF) has a Equity-to-Asset of 0.99 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on KDventures AB and its competitors. This is 11% above median its historical median of 0.89. Over the past decade, KDventures AB's Equity-to-Asset has ranged from 0.07 to 0.99. According to the industry distribution chart, KDventures AB ranks #9 out of 1415 companies in the Biotechnology industry, placing it in the top 0.59999999999999%.
Is KDventures AB's Equity-to-Asset too high?
KDventures AB's current Equity-to-Asset of 0.99 is 11% above median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.99. The Biotechnology industry median Equity-to-Asset is 0.68. KDventures AB's value of 0.99 is 45.6% above this industry median. Based on the distribution chart, KDventures AB ranks #9 out of 1415 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, KDventures AB has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's Equity-to-Asset compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #9 out of 1415 companies for Equity-to-Asset. This places KDventures AB in the top 1% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.68. KDventures AB's value of 0.99 is 45.6% above this benchmark. Historically, KDventures AB's own Equity-to-Asset has ranged from 0.07 to 0.99 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 0.68, KDventures AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Biotechnology company?
The median Equity-to-Asset among Biotechnology companies is 0.68, based on 1,415 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KDventures AB's current Equity-to-Asset of 0.99 is 45.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on KDventures AB and its competitors. For the Biotechnology industry, the median Equity-to-Asset is 0.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current Equity-to-Asset is 0.99, which is 11% above median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current Equity-to-Asset of 0.99. The stock's GF Value™ is $0.65, compared to a current price of $0.26 — trading 60.4% below its estimated fair value. The current Equity-to-Asset is 0.99, which is 11% above median its 10-year median of 0.89 and 45.6% above the Biotechnology industry median of 0.68. KDventures AB's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For KDventures AB (KDEVF), the current Equity-to-Asset is 0.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 60.4% below its estimated GF Value™ of $0.65.
Key valuation signals for KDEVF:
Equity-to-Asset: 0.99 (11% above median its 10-year median of 0.89)
GF Value™: $0.65 vs. price of $0.26 (60.4% below fair value)
Industry Position: 45.6% above the Biotechnology median (#9 of 1415)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
27GF Score
Get the complete analysis for KDEVF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
